NDC Labeler Janssen Biotech, Inc.

Janssen Biotech, Inc. labeler's code is 57894. The labeler has 18 products that have an assigned National Drug Code.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Product Type	Status
57894-030	Remicade	Infliximab	Injection, Powder, Lyophilized, For Solution	Intravenous	Human Prescription Drug	ACTIVE
57894-054	Stelara	Ustekinumab	Solution	Intravenous	Human Prescription Drug	ACTIVE
57894-060	Stelara	Ustekinumab	Injection, Solution	Subcutaneous	Human Prescription Drug	ACTIVE
57894-061	Stelara	Ustekinumab	Injection, Solution	Subcutaneous	Human Prescription Drug	ACTIVE
57894-070	Simponi	Golimumab	Injection, Solution	Subcutaneous	Human Prescription Drug	ACTIVE
57894-071	Simponi	Golimumab	Injection, Solution	Subcutaneous	Human Prescription Drug	ACTIVE
57894-111	Carvykti	Ciltacabtagene Autoleucel	Injection, Suspension	Intravenous	Cellular Therapy	ACTIVE
57894-150	Zytiga	Abiraterone Acetate	Tablet	Oral	Human Prescription Drug	ACTIVE
57894-160	Infliximab	Infliximab	Injection, Powder, Lyophilized, For Solution	Intravenous	Human Prescription Drug	ACTIVE
57894-195	Zytiga	Abiraterone Acetate	Tablet, Film Coated	Oral	Human Prescription Drug	ACTIVE
57894-350	Simponi Aria	Golimumab	Solution	Intravenous	Human Prescription Drug	ACTIVE
57894-449	Tecvayli	Teclistamab	Injection	Subcutaneous	Human Prescription Drug	ACTIVE
57894-450	Tecvayli	Teclistamab	Injection	Subcutaneous	Human Prescription Drug	ACTIVE
57894-501	Rybrevant	Amivantamab	Injection	Intravenous	Human Prescription Drug	ACTIVE
57894-502	Darzalex	Daratumumab	Injection, Solution, Concentrate	Intravenous	Human Prescription Drug	ACTIVE
57894-503	Darzalex Faspro	Daratumumab And Hyaluronidase-fihj (human Recombinant)	Injection	Subcutaneous	Human Prescription Drug	ACTIVE
57894-505	Darzalex Iv	Daratumumab	Injection, Solution, Concentrate	Intravenous	Human Prescription Drug	ACTIVE
57894-640	Tremfya	Guselkumab	Injection	Subcutaneous	Human Prescription Drug	ACTIVE